About conolidine
Andy Chevigné and his group, RTI-5152-twelve is postulated to enhance the amounts of opioid peptides that bind to classical opioid receptors inside the brain, causing heightened painkilling activity. The LIH-RTI study groups recognized a collaboration agreement and filed a joint patent application in December 2020.Pathophysiological adjustments in